[{"Assets_0_Q2_USD":869919000.0,"CommonStockSharesOutstanding_0_Q2_shares":84183000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-66927000.0,"NetIncomeLoss_1_Q2_USD":-23420000.0,"NetIncomeLoss_2_Q2_USD":-64817000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":43952000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":75876000.0,"StockholdersEquity_0_Q2_USD":495531000.0,"Ticker":"FGEN","CIK":"921299","name":"FIBROGEN INC","OfficialName":"FibroGen Inc Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"987680900.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180807"}]